Navigation Links
Romosozumab Phase 2 Data Published In New England Journal Of Medicine Show Significant Increases In Bone Mineral Density At Both Spine And Hip
Date:1/1/2014

re subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission (SEC) reports filed by Amgen, including Amgen's most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and Form 8-K. Please refer to Amgen's most recent Forms 10-K, 10-Q and 8-K for additional information on the uncertainties and risk factors related to Amgen's business. Unless otherwise noted, Amgen is providing this information as of Jan. 1, 2014, and expressly disclaims any duty to update information contained in this news release.

No forward-looking statement can be guaranteed and actual results may differ materially from those Amgen projects. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, preclinical results do not guarantee safe and effective performance of product candidates in humans. The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models. The length of time that it takes fo
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. NW Bios International Phase III GBM Brain Trial Is Subject Of BBC TV Report In The UK
2. Amgen Announces Positive Top-Line Results From 52-Week Phase 3 DESCARTES Study Of Evolocumab (AMG 145) In Patients With High Cholesterol
3. CMC Biologics and OncoSynergy Enter into Agreement to Develop and Manufacture Material for IND Enabling Studies and Phase I Clinical Trials
4. ARGX-110, a Novel Anti-CD70 Antibody, Meets Translational Development Goals in Dose Escalation Part of Phase Ib Cancer Study
5. BioLineRx Announces Promising Initial Phase 2 Results of Acute Myeloid Leukemia Treatment
6. FDA Grants Approval of IND to Commence a Phase 3 Pivotal Study for ST10 for the Treatment of Iron Deficiency Anaemia in Chronic Kidney Disease
7. BioSpecifics Technologies Corp. Announces Initiation of Phase 2b Trial of CCH for Treatment of Frozen Shoulder Syndrome
8. Celsion Corporation Announces Combined Clinical Data from Two Phase I Trials at the 2013 San Antonio Breast Cancer Conference
9. AcelRx Pharmaceuticals Presents ARX-04 Dose-Finding Phase 2 Study Data at Anesthesia Medical Conference
10. Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 2b Frozen Shoulder Syndrome Study of Collagenase Clostridium Histolyticum
11. Otonomy Doses First Subjects in Phase 3 Clinical Trials of OTO-201 in Pediatric Patients Undergoing Ear Tube Placement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 19, 2014 In ... research and marketing communication tools are essential for ... competitive – consequently consumers, desires, preferences, and unmet ... environment, market research groups across all industries are ... communication tools. However, the adoption of new market ...
(Date:12/19/2014)... , Dec. 18, 2014 Research and ... the addition of the "Micro Market Monitor: ... to their offering. ... treatment is progressing steadily, which has resulted in ... devices market. The main purpose of these dermatology ...
(Date:12/19/2014)... Ky. , Dec. 18, 2014 Baptist Health ... States to receive full Atrial Fibrillation with Electrophysiology ... Care (SCPC). Atrial fibrillation is the most common ... that in some cases can lead to stroke and possible ... United States have atrial fibrillation and the numbers ...
Breaking Medicine Technology:Study Uncovers New Tools and Techniques for Understanding Consumer Decision Making 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3
... Campbell Alliance, an inVentiv Health company and ... pharmaceutical and biotech industry, today announced the appointment ... Mr. Naeymi-Rad, formerly Chief Operating Officer, succeeds John ... years ago. (Photo: http://photos.prnewswire.com/prnh/20110908/CL64996 ...
... Campbell Alliance, an inVentiv Health ... the pharmaceutical and biotech industry, today announced executive promotions ... Earlier today, Campbell Alliance announced that Nader ... of Chief Executive Officer.  The firm is also making ...
Cached Medicine Technology:Nader Naeymi-Rad Appointed CEO of Campbell Alliance 2Nader Naeymi-Rad Appointed CEO of Campbell Alliance 3Nader Naeymi-Rad Appointed CEO of Campbell Alliance 4Nader Naeymi-Rad Appointed CEO of Campbell Alliance 5Campbell Alliance Announces Executive Promotions and Organizational Changes 2Campbell Alliance Announces Executive Promotions and Organizational Changes 3Campbell Alliance Announces Executive Promotions and Organizational Changes 4Campbell Alliance Announces Executive Promotions and Organizational Changes 5Campbell Alliance Announces Executive Promotions and Organizational Changes 6
(Date:12/20/2014)... Viejo, California (PRWEB) December 20, 2014 ... announced the release of a new plugin for Final ... Film Studios. , “TranSlice Volume 5 allows users to ... hand draw it.” Said Christina Austin, CEO of Pixel ... add level of professionalism while maintaining an easy to ...
(Date:12/20/2014)... Today, Balfleet.com, one of the most ... offering 50%-70% off on its Mother of the ... mother of the bride dresses from Balfleet.com feature gorgeous ... accessible and takes pride in providing high quality dresses ... offering great discounts on our mother of the bride ...
(Date:12/19/2014)... Sub Zero Ice Cream is partnering up with the Suncoast ... from 2pm-6pm at the Expo Center on the northeast corner ... Inquiries regarding time slots and signing up, email todd.subzeroicecream(at)gmail(dot)com. As ... Sub Zero Ice Cream & Yogurt will be offering all ... Sub Zero Ice Cream & Yogurt , Sub Zero ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 SuperCloset raises ... SuperClone Rooms. SuperCloset continues to offer indoor growers the ... one of the new SuperClone Rooms with the award ... and turnkey indoor hydroponic grow room setup. , The ... world, SuperCloset’s SuperPonic SuperCloner 50 . ...
(Date:12/19/2014)... (PRWEB) December 20, 2014 The Medspa ... new injectable filler from respected cosmetic brand Juvéderm. Voluma ... naturally with age. The Medspa at Hendrick is pleased ... in skin care technology to its clients. , Voluma ... to be FDA-approved to treat the mid-face and cheek ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios released a new transition entitled TranSlice Volume 5 exclusively for Final Cut Pro X 2Health News:Balfleet.com is Offering 50%-70% Off of its Mother of the Bride Dresses 2Health News:Shark Tank’s Sub Zero Ice Cream Sponsors Blood Drive 2Health News:SuperCloset Continues to Innovate with New Complete Indoor Grow Room Packages, The SuperClone Rooms are the Newest Addition to the Award Winning SuperRoom Lineup 2Health News:Breakthrough New Injectable Dermal Filler Voluma XC Offered by The MedSpa at Hendrick 2
... the Nissan Quest,and their families can breathe easy when ... is thanks to micronAir(R) combination filters - a,product of ... on the Quest. The combination filters from micronAir ... the HVAC system, reducing offensive odors as well as,gaseous ...
... Amsterdam, November 6, 2007 Elsevier announced ... AG, headquartered in Leverkusen, Germany, has signed an ... electronic format for the first time, EMBASE Classic ... 43 Excerpta Medica Abstract Journals published between 1947 ...
... vitamins and electrolytes offer healthiest ... benefits in new functional water, PLANO, Texas, Nov. ... punch, Snapple,s introduction of Antioxidant Water and,LYTeWater takes drinking water to ... smart solution that,improves energy, helps restore the body and supports a ...
... Micromet, Inc. (Nasdaq:,MITI), a biopharmaceutical company ... cancer, inflammation and autoimmune diseases,announced the publication ... mode of,action of Micromet,s bispecific BiTE antibody ... of Immunotherapy(1) and in Cancer Immunology,Immunotherapy(2), respectively. ...
... BioElectronics,Corporation, (Pink Sheets: BIEL), announced today that Michael ... Vice President of Sales. Mr. Seidenman is ... well versed in electro medicine devices. He brings ... device sales,management. Mr. Seidenman has launched many new ...
... Nov. 6 /PRNewswire-FirstCall/ - Lorus Therapeutics Inc.,(,Lorus,), a ... of pharmaceutical products and,technologies for the management of ... at 10:30 a.m. EST (Eastern Standard Time), Dr.,Aiping ... corporate overview of the,Company at the Acumen BioFin ...
Cached Medicine News:Health News:Quality Control: Nissan Quest to Feature micronAir(R) Combination Cabin Air Filters 2Health News:EMBASE Classic makes inroads into pharmaceutical industry 2Health News:Snapple's New Antioxidant Water and LYTeWater Take Hydration to the Next Level 2Health News:Snapple's New Antioxidant Water and LYTeWater Take Hydration to the Next Level 3Health News:Micromet's BiTE(R) Antibodies Reveal Unique Mode of Action 2Health News:Micromet's BiTE(R) Antibodies Reveal Unique Mode of Action 3Health News:Micromet's BiTE(R) Antibodies Reveal Unique Mode of Action 4Health News:Micromet's BiTE(R) Antibodies Reveal Unique Mode of Action 5Health News:BioElectronics Corporation Announces Addition of Michael Seidenman, R.Ph. as Vice President of Sales 2Health News:Lorus announces presentation of corporate overview at the Rodman and Renshaw Annual Healthcare Conference 2
... combined with the ultimate space efficient ... the new Topcon Express Lane the ... Century practice environments: Ultimate Space EfficiencyComplete, ... in an 8' X 9' room ...
... For those who need to move their ... a handy portable solution. The IMAGEnet Portable System ... built-in flat panel monitor. This portable PC solution ... camera choices to be tailored to your multi-site ...
... Topcon combines the best 32-bit software package ... hardware offerings to bring you a fast ... cost efficient "mid-resolution" package takes advantage of ... adds the latest graphics capture technology and ...
Inquire...
Medicine Products: